Archived Newsletters
-
05.16.24 -- The ADC Market To Triple By 2030, Driven By Big Pharma Developments
5/16/2024
05/16/24 Outsourced Pharma Newsletter
-
05.16.24 -- You Want To Rein In China? Then Actually Do It
5/16/2024
05/16/24 Outsourced Pharma Newsletter
-
05.15.24 -- Discover Clinical Supply Partners Ready For Your Clinical Studies
5/15/2024
05/15/24 Outsourced Pharma Newsletter
-
05.15.24 -- A Good Feeling ($$) About Contract Manufacturing
5/15/2024
05/15/24 Outsourced Pharma Newsletter
-
05.14.24 -- Accelerate Cell & Gene Therapies: Development, Workflows, & Commercialization Strategies
5/14/2024
05/14/24 Outsourced Pharma Newsletter
-
05.14.24 -- Nothing To See Here! Just Big Pharma Investments In China
5/14/2024
05/14/24 Outsourced Pharma Newsletter
-
05.13.24 -- Let's deviate from deviations - Sterile drugs.
5/13/2024
05/13/24 Outsourced Pharma Newsletter
-
05.13.24 -- Stop Fixating On CDMO Pricing!
5/13/2024
05/13/24 Outsourced Pharma Newsletter
-
05.10.24 -- Meeting The Demand For Cell & Gene Therapy Commercialization
5/10/2024
05/10/24 Outsourced Pharma Newsletter
-
05.10.24 -- What Time Is Best To Bring My CDMO On Board?
5/10/2024
05/10/24 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more